Phathom Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $16,352 | $7,324 | $1,912 | $682 |
Gross Profit | 13,996 | 5,948 | 1,486 | 905 |
EBITDA | -66,902 | -73,485 | -65,470 | -66,356 |
EBIT | -67,093 | -73,682 | -65,684 | -66,541 |
Net Income | -85,577 | -91,446 | -82,852 | -79,570 |
Net Change In Cash | 16,352 | 7,324 | 1,912 | 682 |
Free Cash Flow | -63,487 | -70,767 | -69,060 | -44,272 |
Cash | 334,678 | 276,237 | 322,229 | 381,393 |
Basic Shares | 64,627 | 58,558 | 58,371 | 51,289 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $682 | $0 | $0 | $0 |
Gross Profit | 515 | -620 | -521 | -300 |
EBITDA | -159,049 | -171,820 | -134,559 | -124,187 |
EBIT | -159,624 | -172,440 | -135,080 | -124,487 |
Net Income | -201,592 | -223,006 | -148,094 | -133,318 |
Net Change In Cash | 682 | 0 | 0 | 0 |
Cost of Revenue | -104,237 | 43,731 | ||
Free Cash Flow | -139,214 | -147,571 | -148,945 | -70,728 |
Cash | 381,393 | 155,385 | 183,259 | 287,496 |
Basic Shares | 51,289 | 39,118 | 37,002 | 33,228 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.32 |
2024-06-30 | -$1.56 |
2024-03-31 | -$1.42 |
2023-12-31 | -$1.39 |
